Urinary and Sexual Function After Radical Prostatectomy for Clinically Localized Prostate Cancer: The Prostate Cancer Outcomes Study

Article Abstract:

Men with prostate cancer who have surgery to remove the prostate gland may develop impotence and urinary incontinence. In a study of 1,291 men with prostate cancer who had their prostate removed, 8% were incontinent 18 months or more after surgery and 60% were impotent. Men who had surgery that spared nerves were less likely to have impotence. Older men were more likely to develop impotence and incontinence than younger men. Whites and Hispanics were also more likely to develop impotence and incontinence than blacks.

Causes of, Complications and side effects, Urinary incontinence, Surgery, Prostatectomy, Impotence

---

20-year outcomes following conservative management of clinically localized prostate cancer

Article Abstract:

A study was conducted to estimate 20-year survival based on a competing risk analysis of men who were diagnosed with clinically localized prostate cancer. The result showed that the annual mortality rate from prostate cancer appears to remain stable after 15 years from diagnosis, which does not support aggressive treatment for localized low-grade prostate cancer.

United States, Patient outcomes, Men, Men's health

---

The role of increasing detection in the rising incidence of prostate cancer

Article Abstract:

The number of prostate cancer cases rose between 1986 and 1991 which may be due to increased use of the prostate specific antigen (PSA) test. The PSA test measures blood levels of a protein that is secreted by the prostate gland. Men with prostate cancer have abnormally high levels of this protein. Researchers reviewed tumor registry data and physicians' Medicare claims data collected in four regions of the US between 1986 and 1991. Investigators used the data to study prostate cancer rates and the use of procedures to detect prostate cancer. During the six-year study period, the prostate cancer rate increased by almost 82%. Nearly three times more prostate needle biopsies were performed and 15% fewer transurethral prostate resection procedures were undertaken to detect prostate cancer. Use of the PSA test increased between 1988 and 1991. PSA tests precipitated 10% of needle biopsies in 1988 and 50% of needle biopsies in 1991.

Usage, Diagnosis, Medical screening, Health screening

Similar abstracts:

• Abstracts: Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer
• Abstracts: Drug Dependence, a Chronic Medical Illness: Implications for Treatment, Insurance, and Outcomes Evaluation. The effects of psychosocial services in substance abuse treatment
• Abstracts: Chinese and US Health Care Leaders Discuss Challenges of the 21st Century. Nanoscale biosensors show promise
• Abstracts: Recalls and Safety Alerts Involving Pacemakers and Implantable Cardioverter-Defibrillator Generators. Safety Alerts Involving Device Therapy for Arrhythmias
• Abstracts: Two - photon fluorescence correlation microscopy reveals the two - phase nature of transport in tumors. Recognition of tumor blood vessel normalization as a new antiangiogenic concept

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.